Back

Utility of polygenic risk score for prediction of dilated cardiomyopathy and modulation of severity of LV dysfunction among cases

30 August 2024 (15:00 - 15:50)
Organised by: Logo
Congress Presentation Part of: Dilated cardiomyopathies: miscellaneous aspects Dilated Cardiomyopathy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Ms Daria Kramarenko

Amsterdam University Medical Centre (AUMC), Amsterdam (Netherlands (The))

7 More presentations in this session

Presentation thumbnail
Cardiac sympathetic innervation, assessed with 123I-MIBG SPECT, predicts left ventricular function improvement in patients with newly diagnosed dilated cardiomyopathy
Doctor E. Dziewiecka (Krakow, PL)
Abstract Slides Video
Presentation thumbnail
Subclinical myocardial phenotype in genotype-positive relatives attending clinical and genetic screening for familial dilated cardiomyopathy
Doctor T. Rasmussen (Aarhus N, DK)
Abstract Slides Video
Presentation thumbnail
The added value of advanced echocardiography in dilated cardiomyopathy: looking at the right heart
Assistant Professor D. Hadareanu (Craiova, RO)
Abstract Slides Video
Presentation thumbnail
A systematic review and meta-analysis to determine the biological sex ratio in monogenic genetic and non-genetic dilated cardiomyopathy
Doctor I. Prachee (London, GB)
Abstract Slides Video
Presentation thumbnail
Improving the yield of genetic testing in dilated cardiomyopathy using late gadolinium enhancement
Doctor A. Ferreira (Vila Franca de Xira, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Dilated cardiomyopathies: miscellaneous aspects

The Event

Event poster

ESC Congress 2024

30 August 2024 15:00 CET
You may be interested in
thumbnail
Congress Presentation
Utility of polygenic risk scores for dilated cardiomyopathy in the general population
29 August 2025
thumbnail
Congress Presentation
Prognostic implications of genotype findings in non-ischemic dilated cardiomyopathy: a network meta-analysis
2 September 2024
thumbnail
Congress Presentation
Large-scale genetic and multi-omics analyses identify molecular pathways underlying dilated cardiomyopathy
27 August 2023
thumbnail
Congress Presentation
Polygenic risk score for hypertrophic cardiomyopathy predicts population disease risk, penetrance in sarcomeric rare variant carriers and survival in cases
26 August 2023

ESC 365 is supported by

Lilly Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

Lilly Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources